Your Position:Home>Products>Monoclonals/Polyclonals>Carlumab ELISA Kit

Carlumab ELISA Kit

  • Cat. No.:RB9TDY280018
  • Price:Negotiable
  • Clicks:212

Product Detail

Product Parameters

ApplicationsELISA
Detection MethodColorimetric
Sensitivity0.156 μg/ml
Detection Range0.31-5 μg/mL
Recovery80-120%
Sample TypePlasma, Serum
Assay TypeQuantitative
Stability and StorageThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping Condition2-8 ℃
Accession NumberP13500
BackgroundCarlumab, developed by Janssen Biotech, is a recombinant human IgG1 monoclonal antibody targeting CC chemokine ligand 2 (CCL2). The recombinant protein has been developed for the treatment of cancer and prostate cancer, and has also been studied in systemic sclerosis, atherosclerosis, diabetic nephropathy, liver fibrosis, and type 2 diabetes. In the beginning, phage display technology was used to confirm the high affinity between Carlumab and CCL2, which provided a basis for future clinical trials. In 2013, Carlumab was used to treat metastatic castrated prostate cancer and solid tumors. The anti-tumor activity of Carlumab was preliminarily determined through the study of its safety, tolerance, pharmacokinetics-pharmacodynamics and anti-tumor activity. Subsequently, some studies have evaluated the safety and efficacy of Carlumab in the treatment of (IPF) with idiopathic pulmonary fibrosis, but the results are not satisfactory. Due to the limited success rate of clinical trials, carlumab was discontinued in 2012.
Alternative NamesCNTO 888, 915404-94-3
NoteFor Research Use Only.
For Research Use Only. Not for Diagnostic Procedures.

Related Products:
Total 33055 records,Divided into 1653 pages,The 1 pages | First Prev Next Last
Live Chat
  • Tel:
  • WeChat ID: 15898894496
  • Add Message
  • 9:00 AM – 6:00 PM